Skip to main content

Peer Review reports

From: Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial

Original Submission
10 Mar 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
21 Aug 2023 Reviewed Reviewer Report
1 Sep 2023 Reviewed Reviewer Report
28 Sep 2023 Author responded Author comments - William HK Schilling
Resubmission - Version 4
28 Sep 2023 Submitted Manuscript version 4
29 Sep 2023 Author responded Author comments - William HK Schilling
Resubmission - Version 5
29 Sep 2023 Submitted Manuscript version 5
7 Oct 2023 Reviewed Reviewer Report
20 Nov 2023 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
21 Nov 2023 Editorially accepted
15 Jan 2024 Article published 10.1186/s12879-023-08835-3

You can find further information about peer review here.

Back to article page